Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: Lack of correlation with serum alpha-fetoprotein levels
Journal of the National Cancer Institute
Saved in:
Main Authors: | Ren, E.C., Chan, S.H. |
---|---|
Other Authors: | WHO IMMUNOLOGY RESEARCH & TRAINING CTR |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/132705 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The use of alpha-fetoprotein for detecting hepatocellular carcinoma may potentially be more beneficial for patients with aggressive hepatocellular carcinomas and high alpha-fetoprotein levels
by: Waraporn Panjawong, et al.
Published: (2019) -
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
by: Narongsak Rungsakulkij, et al.
Published: (2019) -
Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker
by: Chen, L., et al.
Published: (2014) -
Serum AFP (Alpha Fetoprotein) levels profile of hepatocellular carcinoma patients in Dr.
Soetomo General Academic Hospital, Surabaya, Indonesia
by: Dyeneka Rustanti Indreswara Putri, et al.
Published: (2022) -
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: Evaluation of alpha-fetoprotein as a diagnostic marker
by: S. Songsivilai, et al.
Published: (2018)